IIM
EW icon

IFC & Insurance Marketing’s Edwards Lifesciences EW Stock Holding History

IFC & Insurance Marketing’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39
Closed -$3K – 245
2025
Q4 		$3K Buy
+39
New +$3.2K ﹤0.01% 580

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

IFC & Insurance Marketing's EW Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 39 shares — an estimated $3K sold.

IFC & Insurance Marketing first reported a position in EW in Q4 2025 and held it in 1 quarter. The position peaked at $3K in Q4 2025. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • IFC & Insurance Marketing reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • IFC & Insurance Marketing sold 39 Edwards Lifesciences shares in Q1 2026, an estimated $3K.
  • IFC & Insurance Marketing first reported a position in Edwards Lifesciences in Q4 2025 and held it in 1 quarter.
  • IFC & Insurance Marketing's Edwards Lifesciences position peaked at $3K in Q4 2025.
  • 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.